These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24231556)

  • 1. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
    Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study.
    Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni E; Carubbi F; Gregoraci G; Gandolfo S; Salvin S; Luciano N; Minniti A; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    Scand J Rheumatol; 2015; 44(1):36-41. PubMed ID: 25268749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
    Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
    Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
    Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease.
    Argyropoulou OD; Pezoulas V; Chatzis L; Critselis E; Gandolfo S; Ferro F; Quartuccio L; Donati V; Treppo E; Bassoli CR; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos TE; Mavragani CP; Baldini C; Skopouli FN; Galli M; Fotiadis DΙ; De Vita S; Moutsopoulos HM; Tzioufas AG; Goules AV
    Semin Arthritis Rheum; 2020 Oct; 50(5):846-853. PubMed ID: 32896698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.
    De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome.
    Baldini C; Pepe P; Luciano N; Ferro F; Talarico R; Grossi S; Tavoni A; Bombardieri S
    J Rheumatol; 2012 Apr; 39(4):804-8. PubMed ID: 22337248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
    Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
    Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease].
    Vasil'ev VI; Probatova NA; Varlamova EIu; Tupitsin NN; Simonova MV; Safonova TN; Bozh'eva LA; Shornikova NS; Logvinenko OA; Belenin GIu
    Ter Arkh; 2004; 76(8):61-8. PubMed ID: 15471400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
    Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
    Risselada AP; Kruize AA; Bijlsma JW
    Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the patients with primary Sjögren's syndrome complicated with lymphoma].
    Li YQ; Yu QM; Li J; Yang JR; Niu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):467-9. PubMed ID: 22812260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of patients with primary Sjögren's syndrome and non-Hodgkin's lymphoma: analysis of 9 cases].
    Jia N; Tang FL
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(39):2786-8. PubMed ID: 20137605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
    Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
    Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
    Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
    Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
    Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
    Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan.
    Weng MY; Huang YT; Liu MF; Lu TH
    Ann Rheum Dis; 2012 Apr; 71(4):524-7. PubMed ID: 22072014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
    Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
    Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.